Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Biopharmaceuticals thus far approved in the USA or European Union

Notes (a) Several products have been approved for multiple indications. Only the first indication for which each was approved is listed, (b) Vet listing in therapeutic indication column indicates an animal application. All other products are used in human medicine. [Pg.499]

Product Company Therapeutic indication Date approved [Pg.499]

Bioclate (rhFactor VIII produced in CHO cells) Centeon Haemophilia A 1993 (USA) [Pg.499]

Beneflx (rhFactor IX produced in CHO cells) Genetics Institute Haemophilia B 1997 (USA, EU) [Pg.499]

Kogenate (rhFactor VIII produced in BHK cells. Also sold as Helixate by Centeon via a license agreement) Bayer Haemophilia A 1993 (USA), 2000 (EU) [Pg.499]

See other pages where Biopharmaceuticals thus far approved in the USA or European Union is mentioned: [Pg.499]   


SEARCH



Biopharmaceuticals

Biopharmaceutics

European Union biopharmaceuticals

FARS

In European Union

The European Union

© 2024 chempedia.info